Reuters logo
BRIEF-Bluebird Bio, Apceth Biopharma establish commercial drug product manufacturing agreement
December 15, 2016 / 1:29 PM / 9 months ago

BRIEF-Bluebird Bio, Apceth Biopharma establish commercial drug product manufacturing agreement

Dec 15 (Reuters) - Bluebird Bio Inc :

* Bluebird Bio and Apceth Biopharma establish commercial drug product manufacturing agreement

* Bluebird Bio- under deal, Apceth Biopharma will perform clinical manufacturing, process validation activities, commercial manufacturing for lentiglobin, lenti-d

* Bluebird Bio Inc - under agreement, Apceth Biopharma will perform clinical manufacturing for lentiglobin and lenti-d drug product Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below